X

Indian Stock Market

UFO Moviez reports lower revenue and profit in Q3 FY26 amid decline in advertising income

UFO Moviez India Limited (BSE: 539141 / NSE: UFO) reported a decline in revenue and profitability in the quarter ended…

Dodla Dairy posts revenue growth in Q3 FY26 as margins narrow amid higher procurement costs

Dodla Dairy Ltd (BSE: 543306 / NSE: DODLA) reported higher revenue in the quarter ended December 2025, supported by volume…

Canara Robeco AMC expanding distribution reach and equity-led AUM shape platform economics in Q3 FY26

Canara Robeco Asset Management Company Ltd (BSE: 544580 / NSE: CRAMC) continues to scale its asset management platform through a…

Nuvama Wealth Management – scale of client assets increasingly shapes earnings sensitivity and business mix

Nuvama Wealth Management Ltd (NSE: NUVAMA / BSE: NUVAMA) is transitioning from a transaction-led capital markets business to a scale-driven…

Nuvama Wealth Management: diversification across wealth, asset management and capital markets shapes earnings profile in Q3 FY26

Nuvama Wealth Management Ltd (NSE: NUVAMA / BSE: NUVAMA) continues to operate a diversified financial services platform spanning wealth management,…

Nuvama Wealth Management posts marginal revenue growth in Q3 FY26 as wealth business expands

Nuvama Wealth Management Ltd (NSE: NUVAMA / BSE: NUVAMA) reported consolidated revenue of ₹755 crore for the quarter ended December…

Canara Robeco Asset Management Company Ltd reports Q3 FY26 PAT of ₹528 million, AUM at ₹1.2 trillion

Canara Robeco Asset Management Company Ltd (BSE: 544580 / NSE: CRAMC) reported total income of ₹1,215 million and profit after…

OneSource Specialty Pharma Ltd operational scale expands amid near-term earnings volatility

OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) has emerged as a multi-modality contract development and manufacturing organisation (CDMO)…

OneSource Specialty Pharma Ltd reports Q3 FY26 revenue of ₹2.9 billion, EBITDA declines amid approval delays

OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) reported consolidated revenue of ₹2.9 billion for the quarter ended December…

Coforge Q3 FY26 revenue rises YoY, margin declines QoQ

Coforge Ltd (BSE: 532541 / NSE: COFORGE) reported consolidated revenue of ₹41,881 million for the quarter ended December 31, 2025,…